Insider trades
Rohan Palekar, Director of Neurogene NGNE, has filed 2 purchases and 5 sales on the open market. The latest trade was on 02/20.
Rohan Palekar
Director
- Company
- Neurogene NGNE
- First filing
- 23/02/13
- Trades
- 52 trades
- Buys / sales
- 2 / 5
- 12-month net buying
- No record
- Last trade
- 02/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 24/12/06 | 24/12/10 | 5,000 sh | $7.89 | $39,450 | +1.1% | |
| Open-market buy | 24/11/22 | 24/11/25 | 10,000 sh | $8.35 | $83,500 | +2.2% | |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 52,718 sh | $10.91 | $575,153.38 | −10.3% | |
| Open-market sale10b5-1 plan | 24/02/26 | 24/02/28 | 4,477 sh | $10.76 | $48,172.52 | −0.9% | |
| Open-market sale10b5-1 plan | 23/12/29 | 24/01/03 | 50,000 sh | $11.20 | $560,000 | −14.2% | |
| Open-market sale | 23/06/05 | 23/06/07 | 15,000 sh | $20.00 | $300,000 | −5.0% | |
| Open-market sale | 23/03/23 | 23/03/27 | 15,000 sh | $16.00 | $240,000 | −5.3% |